Permutation Test (PT) and Tolerated Difference Test (TDT): two new, robust and powerful nonparametric tests for statistical comparison of dissolution profiles.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Name:
Gomez-Mantilla et al_final.pdf
Size:
531.1Kb
Format:
PDF
Description:
original manuscript
Name:
Mantilla_Test_Figures_SUPPORTI ...
Size:
7.070Mb
Format:
PDF
Description:
sipporting material
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2013-01-30
Metadata
Show full item recordAbstract
The most popular way of comparing oral solid forms of drug formulations from different batches or manufacturers is through dissolution profile comparison. Usually, a similarity factor known as (f2) is employed; However, the level of confidence associated with this method is uncertain and its statistical power is low. In addition, f2 lacks the flexibility needed to perform in special scenarios. In this study two new statistical tests based on nonparametrical Permutation Test theory are described, the Permutation Test (PT), which is very restrictive to confer similarity, and the Tolerated Difference Test (TDT), which has flexible restrictedness to confer similarity, are described and compared to f2. The statistical power and robustness of the tests were analyzed by simulation using the Higuchi, Korsmayer, Peppas and Weibull dissolution models. Several batches of oral solid forms were simulated while varying the velocity of dissolution (from 30 min to 300 min to dissolve 85% of the total content) and the variability within each batch (CV 2-30%). For levels of variability below 10% the new tests exhibited better statistical power than f2 and equal or better robustness than f2. TDT can also be modified to distinguish different levels of similarity and can be employed to obtain customized comparisons for specific drugs. In conclusion, two new methods, more versatile and with a stronger statistical basis than f2, are described and proposed as viable alternatives to that method. Additionally, an optimized time sampling strategy and an experimental design-driven strategy for performing dissolution profile comparisons are described.Citation
Permutation Test (PT) and Tolerated Difference Test (TDT): two new, robust and powerful nonparametric tests for statistical comparison of dissolution profiles. 2013, 441 (1-2):458-67 Int J PharmAffiliation
Biopharmaceutics and Pharmaceutical Technology, Saarland University, Campus A4.1, D-66123 Saarbruecken, Germany.PubMed ID
23194886Type
ArticleLanguage
enISSN
1873-3476ae974a485f413a2113503eed53cd6c53
10.1016/j.ijpharm.2012.11.008
Scopus Count
The following license files are associated with this item:
Related articles
- Statistical comparison of dissolution profiles to predict the bioequivalence of extended release formulations.
- Authors: Gomez-Mantilla JD, Schaefer UF, Casabo VG, Lehr T, Lehr CM
- Issue date: 2014 Jul
- A new principal component analysis-based approach for testing "similarity" of drug dissolution profiles.
- Authors: Maggio RM, Castellano PM, Kaufman TS
- Issue date: 2008 May 10
- Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statistic.
- Authors: Novick S, Shen Y, Yang H, Peterson J, LeBlond D, Altan S
- Issue date: 2015
- Assessment of similarity between dissolution profiles.
- Authors: Ma MC, Wang BB, Liu JP, Tsong Y
- Issue date: 2000 May
- Comparison of Dissolution Similarity Assessment Methods for Products with Large Variations: f(2) Statistics and Model-Independent Multivariate Confidence Region Procedure for Dissolution Profiles of Multiple Oral Products.
- Authors: Yoshida H, Shibata H, Izutsu KI, Goda Y
- Issue date: 2017